针对传染病的单克隆抗体疗法
Arturo Casadevall1, Nigel Paneth2
1Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. acasade1@jhu.edu.
Current topics in microbiology and immunology
|June 13, 2024
概括
单克隆抗体 (mAbs) 对传染病具有前景,但其发展落后于其他领域. 挑战包括现有的疗法,微生物多样性和成本,但mAb开发的机会正在增长.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 单克隆抗体 (mAbs) 在瘤学和免疫相关疾病中广泛使用.
- 它们在传染病中的应用显著欠发达,只有很少有许可的治疗方法.
- 鉴于抗体在抗击感染中的自然作用,这是矛盾的.
研究的目的:
- 审查传染病单克隆抗体 (mAb) 开发的现状.
- 确定阻碍mAbs在该领域更广泛应用的挑战.
- 突出未来基于mAb的治疗方法对抗微生物疾病的机会.
主要方法:
- 对获得许可的单克隆抗体 (mAb) 治疗传染病的文献综述.
- 分析导致mAbs在这个治疗领域欠发达的因素.
- 探索潜在的未来应用和研究方向.
主要成果:
- 对于微生物疾病,只有不到十几个单克隆抗体 (mAbs) 获得许可,与其他领域的众多批准形成鲜明对比.
- 主要障碍包括替代治疗的可用性,病原体的抗原多样性和高治疗成本.
- 尽管面临挑战,但对于传染病的批准mAbs的数量正在逐渐增加.
结论:
- 针对传染病的单克隆抗体 (mAbs) 的开发是一个具有重大未满足需求和潜力的领域.
- 克服与病原体变异性和成本相关的挑战对于扩大mAb使用至关重要.
- 需要进一步的研究和开发,以利用mAbs预防和治疗微生物感染.
关键词:
单克隆抗体是一种单克隆抗体.更多相关视频
相关概念视频
01:31Hybridoma Technology
14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:36Humoral Immune Responses
72.5K
Overview
72.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511